Literature DB >> 11083709

Recreational use of aminorex and pulmonary hypertension.

S P Gaine1, L J Rubin, J J Kmetzo, H I Palevsky, T A Traill.   

Abstract

Pulmonary hypertension has been associated with ingestion of the appetite suppressant aminorex. A similar compound, 4-methyl-aminorex (street names, "U-4-E-uh" [pronounced euphoria] or "ice"), is a "designer" drug with central stimulant activity. This drug was discovered on the property of three individuals with diagnoses of pulmonary hypertension. The association between "recreational" aminorex manufacture and ingestion and the development of pulmonary hypertension is described.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083709     DOI: 10.1378/chest.118.5.1496

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.

Authors:  Roham T Zamanian; Haley Hedlin; Paul Greuenwald; David M Wilson; Joshua I Segal; Michelle Jorden; Kristina Kudelko; Juliana Liu; Andrew Hsi; Allyson Rupp; Andrew J Sweatt; Rubin Tuder; Gerald J Berry; Marlene Rabinovitch; Ramona L Doyle; Vinicio de Jesus Perez; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

2.  2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors.

Authors:  Adam L Halberstadt; Simon D Brandt; Donna Walther; Michael H Baumann
Journal:  Psychopharmacology (Berl)       Date:  2019-03-23       Impact factor: 4.530

Review 3.  Drug-induced pulmonary arterial hypertension: a review.

Authors:  Lohit Garg; Ghulam Akbar; Sahil Agrawal; Manyoo Agarwal; Leila Khaddour; Rishin Handa; Aakash Garg; Mahek Shah; Brijesh Patel; Bhavinkumar D Dalal
Journal:  Heart Fail Rev       Date:  2017-05       Impact factor: 4.214

Review 4.  Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

Authors:  Richard B Rothman; Bruce E Blough; Michael H Baumann
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

Review 5.  DARK Classics in Chemical Neuroscience: Aminorex Analogues.

Authors:  Julian Maier; Felix P Mayer; Simon D Brandt; Harald H Sitte
Journal:  ACS Chem Neurosci       Date:  2018-10-05       Impact factor: 5.780

6.  Characterization of a recently detected halogenated aminorex derivative: para-fluoro-4-methylaminorex (4'F-4-MAR).

Authors:  D Fabregat-Safont; X Carbón; M Ventura; I Fornís; F Hernández; M Ibáñez
Journal:  Sci Rep       Date:  2019-06-05       Impact factor: 4.379

Review 7.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.